All News

sNDA Goes to FDA for neffy 1 mg for Young Children with Type 1 Allergic Reactions
September 11, 2024

The needle-free nasal spray, if approved, would be the first new administration method for epinephrine in young children in 35 years.

Mammography Centers Now Mandated to Disclose Breast Density
September 11, 2024

Regulations have been amended under the Mammography Quality Standards Act of 1992 to ensure women receive quality mammography for early breast cancer detection and prevention.

Congenital Adrenal Hyperplasia Management Across the Lifespan
September 11, 2024

The cortisol deficiency central to congenital adrenal hyperplasia requires lifelong treatment with distinct shifts in management required at each developmental stage.

Healthy Lifestyle May Offset Brain Aging Accelerated by Diabetes: Daily Dose
September 11, 2024

Your daily dose of the clinical news you may have missed.

Lebrikizumab Therapy Improved QoL, Mental Health Outcomes in Patients with Atopic Dermatitis
September 10, 2024

In a study of persons with moderate-to-severe atopic dermatitis, lebrikizumab monotherapy for 16 weeks resulted in improved quality of life and mental health.

RSV Vaccine Proves 75% Effective Against Hospitalization in Older Adults, According to New CDC Data
September 10, 2024

The new data amend that from prelicensure trials, which did not include fair representation of older adults and others more vulnerable to severe RSV disease.

FDA Expands Omnipod 5 AID System Label to Treat T2D: Daily Dose
September 10, 2024

Your daily dose of the clinical news you may have missed.

Novel GLP-1 RA for Obesity Shows Promise in Early Phase 1 Trial
September 09, 2024

Once-daily oral TERNS-601 was associated with a significant mean 5% weight reduction after 28 days and had a favorable tolerability profile.

Tralokinumab May be Beneficial for Atopic Dermatitis Treatment in Special Patient Populations
September 09, 2024

In a study of patients with atopic dermatitis, tralokinumab was effective and safe in elderly patients and those with severe comorbidities.

CDC COVID-19 Vaccine Bridge Access Program Ends 4 Months Earlier than Planned
September 09, 2024

The Bridge Access Program allowed Americans who are uninsured or underinsured to receive COVID-19 vaccination at not cost and was ended abruptly last month.